These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

172 related items for PubMed ID: 6508201

  • 41.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 42. Combined local bladder hyperthermia and intravesical chemotherapy for the treatment of high-grade superficial bladder cancer.
    Gofrit ON, Shapiro A, Pode D, Sidi A, Nativ O, Leib Z, Witjes JA, van der Heijden AG, Naspro R, Colombo R.
    Urology; 2004 Mar; 63(3):466-71. PubMed ID: 15028439
    [Abstract] [Full Text] [Related]

  • 43. Superficial transitional cell carcinoma of the ureteral orifice: higher risk of developing subsequent upper urinary tract tumors.
    Chou EC, Lin AT, Chen KK, Chang LS.
    Int J Urol; 2006 Jun; 13(6):682-5. PubMed ID: 16834642
    [Abstract] [Full Text] [Related]

  • 44. [Drug prevention of recurrence in bladder tumors. Intravesical adriblastin instillation following transurethral resection of non-infiltrating bladder tumors].
    Maier U, Kuber W.
    Fortschr Med; 1983 Mar 31; 101(12):535-40. PubMed ID: 6852720
    [Abstract] [Full Text] [Related]

  • 45.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 46.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 47.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 48. [The sensitivity and clinical implications of periodical bladder biopsy following transurethral resection of superficial bladder transitional cell carcinoma].
    Kanematsu A, Tsuji Y, Kanba H, Noguchi T, Kamoto T, Okabe T.
    Hinyokika Kiyo; 2001 Jan 31; 47(1):1-4. PubMed ID: 11235213
    [Abstract] [Full Text] [Related]

  • 49.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 50.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 51.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 52.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 53.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 54. Significance of matrix metalloproteinases and tissue inhibitors of metalloproteinase expression in the recurrence of superficial transitional cell carcinoma of the bladder.
    Hara I, Miyake H, Hara S, Arakawa S, Kamidono S.
    J Urol; 2001 May 31; 165(5):1769-72. PubMed ID: 11342973
    [Abstract] [Full Text] [Related]

  • 55.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 56.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 57. Ciprofloxacin criteria in antimicrobial prophylaxis and bladder cancer recurrence.
    Gurtowska N, Kloskowski T, Drewa T.
    Med Sci Monit; 2010 Oct 31; 16(10):RA218-23. PubMed ID: 20885364
    [Abstract] [Full Text] [Related]

  • 58. Instillation of mitomycin C and doxorubicin in the prevention of recurrent superficial (Ta-T1) bladder cancer.
    Jauhiainen K, Alfthan O.
    Br J Urol; 1987 Jul 31; 60(1):54-9. PubMed ID: 3113524
    [Abstract] [Full Text] [Related]

  • 59.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 60.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.